Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference
Bausch Health Companies Inc. (NYSE/TSX: BHC) announced participation in the J.P. Morgan Global High Yield & Leveraged Finance Conference on March 1, 2022, at 9:15 a.m. ET. Key executives, including CFO Sam Eldessouky and SVP Arthur J. Shannon, will represent the company. Bausch Health focuses on improving health with a range of products in eye health, gastroenterology, and dermatology. The company's commitment to advancing global health and innovative solutions is highlighted.
- Participation in a significant financial conference may enhance investor engagement.
- Continued focus on key therapeutic areas indicates a clear strategic direction.
- Potential investor uncertainty due to ongoing financial challenges not addressed in the PR.
LAVAL, QC, Feb. 24, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that Sam Eldessouky, executive vice president and chief financial officer; William Woodfield, senior vice president and treasurer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the J.P. Morgan Global High Yield & Leveraged Finance Conference in Miami on March 1, 2022 at 9:15 a.m. ET.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Investor Contact: | Media Contact: |
Arthur Shannon | Lainie Keller |
(514) 856-3855 | (908) 927-1198 |
(877) 281-6642 (toll free) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-participation-at-the-jp-morgan-global-high-yield--leveraged-finance-conference-301486938.html
SOURCE Bausch Health Companies Inc.
FAQ
What is the schedule for Bausch Health at the J.P. Morgan Conference?
Who will represent Bausch Health at the conference?
What are the main therapeutic areas Bausch Health focuses on?
Where is the J.P. Morgan Global High Yield & Leveraged Finance Conference held?
